Goldman Sachs Group Inc Quotient LTD Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 May 14, 2024	SELL	$0.16 - $0.31 $8,999 - $17,436	-56,247 Reduced 78.33%	15,557 $2,000
Q3 2022 Nov 10, 2022	SELL	$0.16 - $0.31 $8,999 - $17,436	-56,247 Reduced 78.33%	15,557 $0
Q2 2022 May 14, 2024	BUY	$0.24 - $1.2 $17,232 - $86,164	71,804 New	71,804 $18,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $1.2 $36,022 - $180,112	-150,094 Reduced 67.64%	71,804 $18,000
Q1 2022 May 16, 2022	SELL	$0.94 - $2.38 $9,039 - $22,888	-9,617 Reduced 4.15%	221,898 $266,000
Q4 2021 Feb 14, 2022	SELL	$1.89 - $3.12 $357,463 - $590,098	-189,134 Reduced 44.96%	231,515 $599,000
Q3 2021 Nov 10, 2021	BUY	$2.34 - $3.77 $984,318 - $1.59 Million	420,649 New	420,649 $985,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.